Cy Biopharma Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
Cy Biopharma General Information
Description
Developer of a clinical-stage biotechnology-based platform designed to optimize psychedelics to generate new alternatives for chronic pain. The company's platform combines biochemical extracts with rarer serotonin receptor agonists to create new molecular entities with properties and operates analytical laboratories, enabling healthcare professionals to access non-opioid alternatives with demonstrated anti-inflammatory, neuroplastic, and psychological benefits to relieve chronic pain and treat rare diseases.
Contact Information
Website
www.cybiopharma.com(Operating Subsidiary)
Corporate Office
- Oberneuhofstrasse 6
- 6340 Baar
- Switzerland
Corporate Office
- Oberneuhofstrasse 6
- 6340 Baar
- Switzerland
Cy Biopharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 05-Aug-2026 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Generating Revenue |
Cy Biopharma Patents
Cy Biopharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025235784-A2 | Ergoline derivatives and uses thereof | Pending | 08-May-2024 | ||
| WO-2025235784-A3 | Ergoline derivatives and uses thereof | Pending | 08-May-2024 | ||
| WO-2025235800-A1 | Ergoline derivatives and uses thereof | Pending | 08-May-2024 | ||
| US-20260060994-A1 | Glycosylated compositions and methods of use | Pending | 26-Aug-2022 | ||
| EP-4577219-A1 | Glycosylated psilocin derivatives and methods of use | Pending | 26-Aug-2022 | A61K31/7056 |
Cy Biopharma Signals
Cy Biopharma Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Social Impact Capital | Venture Capital | Minority |
Cy Biopharma FAQs
-
When was Cy Biopharma founded?
Cy Biopharma was founded in 2020.
-
Where is Cy Biopharma headquartered?
Cy Biopharma is headquartered in Baar, Switzerland.
-
What is the size of Cy Biopharma?
Cy Biopharma has 5 total employees.
-
What industry is Cy Biopharma in?
Cy Biopharma’s primary industry is Drug Discovery.
-
Is Cy Biopharma a private or public company?
Cy Biopharma is a Private company.
-
What is Cy Biopharma’s current revenue?
The current revenue for Cy Biopharma is .
-
How much funding has Cy Biopharma raised over time?
Cy Biopharma has raised $17.1M.
-
Who are Cy Biopharma’s investors?
Social Impact Capital has invested in Cy Biopharma.
-
When was Cy Biopharma acquired?
Cy Biopharma was acquired on 05-Aug-2026.
-
Who acquired Cy Biopharma?
Cy Biopharma was acquired by Ensysce Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process